RCS - Induction Healthcare - Report on Video Consultations in Secondary Care

Induction HealthcareAnnouncement

25/10/2021 07:05

RNS Number : 0073Q
  
Induction Healthcare Group PLC 
  
25 October 2021
  
 

Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
 
Report on Video Consultations in Secondary Care
 
A wide range of benefits to patients and the NHS seen by increased use of video consultations
 
Induction (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, welcomes a report on outpatient video consultations by Edge Health for NHS England and NHS Improvement.
 
The report reviews 3 million video consultations on the Attend Anywhere platform between 1 April 2020 and 31 March 2021 and concludes that they have delivered a range of benefits to patients and the NHS. The report highlights the dramatic increase in video consultations cross 171 NHS hospital trusts in England, increasing from 5,000 a month in March 2020 to 340,000 a month a year later.
 
The report highlighted the following benefits of video consultations: 
 
·    Savings of 4.64 million hours (530 years) in patient travel and in-hospital waiting times in total over the year
·    Savings of £40 million in patient travel costs and parking charges 
·    3 million lost work hours were avoided saving the overall economy £108m in lost productivity 
·   14,200 tonnes of greenhouse gas emissions avoided due to fewer hospital journeys 11 million fewer "single-use" PPE items, such as face masks, were consumed, saving the NHS over £1.1 million
·    1,730 hospital-acquired infections were avoided (not including COVID-19 infections) due to fewer visits to hospital sites 
 
The full report can be seen here: www.edgehealth.co.uk/outpatient-video
 
Attend Anywhere became part of Induction Healthcare Group PLC in June 2021, with the enlarged group now providing a comprehensive virtual care platform for hospitals, doctors and patients, ranging from pre-treatment patient support (including digital correspondence, appointment booking and remote triage) to a full range of in-person, telephone and live-video consultations.
 
James Balmain, CEO of Induction, commented: "We are delighted that this report highlights how patients can benefit from video consultations whilst maintaining and even improving the standard of patient care across NHS hospitals. The report is a strong service proof point, providing easy access to data to for new customers and to drive contract renewals. The adoption of video consultation across the UK over the 12 months highlighted in this report has been significant with Attend Anywhere being used to deliver 3 million video consultations in 171 NHS trusts totalling 1.32 million consultation hours. As can be seen, there are many positive benefits to a wider roll-out of video consultations across secondary care and we look forward to supporting this across the NHS."
 
-ENDS-
 
ENQUIRIES
 




Induction
James Balmain, Chief Executive Officer
Dr Hugo Stephenson, Group Executive Director


Via Walbrook PR Ltd: induction@walbrookpr.com




 


 




Singer Capital Markets (Nominated Adviser and Broker)


+44 (0) 20 7496 3000




Philip Davies / Kailey Aliyar 


 




 


 




Walbrook PR Ltd 


induction@walbrookpr.com




Paul McManus / Alice Woodings


Mob: +44(0)7980 541 893 / +44 (0)7407 804 654 




About Induction -  www.inductionhealthcare.com
 
Induction (AIM: INHC) is a leading virtual care platform driving digital transformation of healthcare systems worldwide. Induction solutions enhance the investments hospitals have made and lay the foundation for their future. Our products can enable information sharing between busy doctors, alleviate operational burdens on hospitals or put patients in better control of their care, all while ensuring the highest standards of clinical safety and information security. We unchain staff and patients from the limitations of paper-based and desktop systems, creating substantial time and cost efficiencies.
 
More than 225,000 hospital doctors across multiple territories, including the UK, Ireland, Australia and South Africa, as well as a rapidly growing number of more than 300,000 UK patients, choose Induction solutions.
 
Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting. 
 
Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.
 
Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals. 
 
Induction Attend Anywhere is the UK market leader in secondary care video consultations. It helps hospitals, health systems and other customers offer video consultations to patients and service users as a normal part of day-to-day clinical activity. Our vision is for video consultations to improve lives and help address social, access, equity and sustainability challenges by allowing healthcare providers to determine how and when they see a patient based on each individual case: in-person, via video or on the telephone. 
 
Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.
 
 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NRAZZMZGKZNGMZM